| Old Articles: <Older 1061-1070 Newer> |
 |
The Motley Fool March 16, 2004 David Nierengarten |
Sanofi Slimming Pill Sanofi's new drug, Acomplia, shows promise for weight loss and smoking cessation.  |
CIO March 15, 2004 Alison Bass |
Health-Care I.T As more health-care providers move toward electronic medical records that they can easily share via the Internet, the potential for abuse grows.  |
BusinessWeek March 22, 2004 Arlene Weintraub |
Amgen Opens The Secret Curtain The biotech leader will host analysts and investors to drum up excitement for its pipeline -- and its stock. Will it work?  |
BusinessWeek March 22, 2004 Robert Barker |
St. Jude: An Insider Sign To Investors? St. Jude, the patron saint of lost causes, rarely has needed to look out for his namesake, St. Jude Medical (STJ ). Since its birth in 1976, this maker of artificial heart valves, defibrillators, catheters, and sundry other cardiac devices has led a blessed life. It's in excellent health today. So why are insiders dumping the stock?  |
Science News March 13, 2004 Edna Francisco |
Formula for Failure A bacterium that has been known to cause rare, yet fatal infections in infants appears to be more widespread than scientists have realized.  |
BusinessWeek March 22, 2004 Gene G. Marcial |
Look Who May Be Courting Bioenvision Genzyme may be interested in Bioenvision as well. Why? In 2001, Bioenvision licensed to ILEX the right to co-develop and market in the U.S. and Canada its Clorfarabine, a drug for leukemia. Bioenvision still holds the rights outside North America. The company will soon file for Food & Drug Administration approval of Clorfarabine, which has a $1 billion market potential.  |
The Motley Fool March 11, 2004 Bill Mann |
Pennsylvania Sues Drug Makers Anyone who thinks that the new prescription drug benefit plan (the Medicare Modernization Act) signed by President Bush will have anything resembling predictable expenses needs to pay attention to what's going on in Pennsylvania. The commonwealth filed suit yesterday against 13 large drug companies, accusing them of price manipulation.  |
Technology Research News March 10, 2004 |
Atomic microscope spots viruses Researchers from BioForce Nanosciences Inc., Iowa State University and Des Moines University have combined an atomic force microscope with a method of capturing virus particles to produce a tool that rapidly detects viruses.  |
The Motley Fool March 9, 2004 Rich Smith |
Interpore Gets Transplanted Will its acquisition by medical equipment maker Biomet pay off for Interpore's shareholders?  |
The Motley Fool March 9, 2004 David Nierengarten |
Sepracor's No Sleeper FDA approval for its sleeping medication sends Sepracor's stock up 70%.  |
| <Older 1061-1070 Newer> Return to current articles. |